글로벌 α-아미노-3-하이드록시-5-메틸-4-이소옥사졸프로피온산(AMPA) 수용체 시장 – 2030년까지의 산업 동향 및 예측

α-아미노-3-하이드록시-5-메틸-4-이소옥사졸프로피온산(AMPA) 수용체 시장 분석 및 규모

최근 몇 년 동안, α-아미노-3-하이드록시-5-메틸-4-이소옥사졸프로피온산(AMPA) 수용체 시장은 간질 발병률 증가로 인해 예측 기간 동안 엄청나게 성장할 것으로 예상됩니다. 세계보건기구의 추산에 따르면 약 5천만 명이 간질을 앓고 있습니다. AMPA 수용체 길항제는 부분 발작 치료에 사용되는 항경련제입니다.

Data Bridge Market Research는 2023-2030년 예측 기간 동안 α-아미노-3-하이드록시-5-메틸-4-이속사졸프로피온산(AMPA) 수용체 시장의 성장률을 분석합니다. 언급된 예측 기간 동안 α-아미노-3-하이드록시-5-메틸-4-이속사졸프로피온산(AMPA) 수용체 시장의 예상 CAGR은 약 5.8%입니다. 시장 가치는 2022년에 2억 4,540만 달러이며, 2030년까지 3억 8,530만 달러까지 성장할 것입니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자 및 시장 시나리오와 같은 시장 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

α-아미노-3-하이드록시-5-메틸-4-이소옥사졸프로피온산(AMPA) 수용체 시장 범위 및 세분화

Market Definition

The AMPA receptor (AMPA-R) is a subtype of the ionotropic glutamate receptor that is related with ion channels. They control the flow of calcium and sodium ions into the cell and modulate cell excitability. These receptor antagonists are the anticonvulsants agents that are being used to treat partial-onset seizures in epilepsy patients. They are non-competitive AMPA receptor antagonists, that are involved in excitatory neurotransmission.

Α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) Receptor Market Dynamics

Drivers

• Increased Cases of Epilepsy

The projected proportion of the general population suffering from active epilepsy at a given time is between 4 and 10 per 1000 people. An estimated 5 million people are diagnosed with epilepsy every year worldwide.  Epilepsy affects both females and males and all the age groups with worldwide distribution. The incidence and the occurrence of epilepsy are slightly higher in men than women and tend to be observed the most in the elderly, signifying the higher frequency of neurodegenerative diseases, stroke, and tumors in this age-group. This factor is boosting the market growth.

• Growing Usage of AMPA Receptor in Diagnostic Techniques

The use of AMPA receptors in detecting mutated genes boost the market growth. AMPA receptor antibody is found in a subset of patients suffering from autoimmune limbic encephalitis. Reducing antibody levels may be related with therapeutic response; thus, clinical association must be strongly considered. Many indirect fluorescent antibody assay uses AMPA transfected cell lines to detect and semi-quantify AMPA IgG antibody. This factor boosts the market growth.  

Opportunities

• Rise in Government Initiatives and Funding

There have been growing investments between diverse organizations that can lead to the growth of the market. For instance, American Epilepsy Society granted fund for extended epilepsy treatment up to US$ 50,000 in March 2021 and are projected to support the establishment of national or global multicenter research initiatives. Every award will provide funding for infrastructure development, organisational planning sessions, or pilot studies, that allows the research programme to compete for future investment.

 Restraints/Challenges

• Lack of Skilled Professionals

Lack of trained and skilled professionals which sometimes fail to use AMPA receptors lead to the failure of detection of epilepsy. Thus, this factor hamper the market growth.

This α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) Receptor Market Scope

The α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor market is segmented on the basis of types, application, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Types

• GluA1
• GluA2
• GluA3
• GluA4

Application

• Epilepsy
• Seizures
• Others

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

 Α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) Receptor Market Regional Analysis/Insights

The α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor market is analyzed and market size insights and trends are provided by types, application, distribution channel and end-user as referenced above.

The major countries covered in the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific will be expecting positive growth for α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor market throughout the forecasted period because of the increasing healthcare expenditure and improvements in healthcare infrastructure in this region.

북미는 이 지역에서 간질 사례가 증가함에 따라 시장을 지배하고 있습니다. 게다가 주요 시장 참여자의 증가는 이 지역의 시장 성장률을 더욱 높일 것입니다.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 또한 글로벌 브랜드의 존재와 가용성, 그리고 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.   

경쟁 환경 및 글로벌 α-아미노-3-하이드록시-5-메틸-4-이소옥사졸프로피온산(AMPA) 수용체 시장 점유율 분석

α-아미노-3-하이드록시-5-메틸-4-이속사졸프로피온산(AMPA) 수용체 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 포함됩니다. 위에 제공된 데이터 포인트는 α-아미노-3-하이드록시-5-메틸-4-이속사졸프로피온산(AMPA) 수용체 시장과 관련된 회사의 초점에만 관련됩니다.

α-아미노-3-하이드록시-5-메틸-4-이소옥사졸프로피온산(AMPA) 수용체 시장에서 활동하는 주요 기업은 다음과 같습니다.

• 머크 KGaA(독일)
• 에자이 주식회사(일본)
• 아스트라제네카(영국)
• 사노피(프랑스)
• 노바티스 AG(스위스)
• 애벗(미국)
• F. 호프만-라 로슈 유한회사(스위스)
• Teva Pharmaceutical Industries Ltd. (이스라엘)
• 파이저 주식회사(미국)
• GSK plc (영국)
• WOCKHARDT(인도)
• Novo Nordisk A/S(덴마크)
• Glenmark Pharmaceuticals Limited(인도)
• 시플라 주식회사(미국)
• Bausch Health Companies Inc. (캐나다)
• 오츠카 아메리카 제약 주식회사(미국)
• 존슨앤존슨 프라이빗 리미티드(미국)
• 다케다제약 주식회사(일본)
• 스미토모 주식회사(일본)
• Biocon(인도)

SKU-68110